About lab
One published Lab
Build with this Lab. Run it anywhere.
Use the same immutable release locally or through managed cloud execution, with its exact version and provenance preserved.
Preparing exact examples…
Lockwood2006 - AlzheimersDisease PBPKmodel A mathematical model to predict theeffectiveness of CI-1017 (muscarinic agonist) for Alzheimer'sdisease by evaluating changes in ADAS-cog score. It can be used to explore systemsbiology lockwood2006 alzheimer s disease pbpk dynamics and compare simulation behavior across conditions.
Manifest
{
"io": {
"inputs": [],
"outputs": [
{
"name": "state",
"maps_to": "systemsbiology_sbml_lockwood2006_alzheimer_s_disease_pbpk_model_biomd0000000673_model.state"
},
{
"name": "summary",
"maps_to": "systemsbiology_sbml_lockwood2006_alzheimer_s_disease_pbpk_model_biomd0000000673_model.summary"
},
{
"name": "species_labels",
"maps_to": "systemsbiology_sbml_lockwood2006_alzheimer_s_disease_pbpk_model_biomd0000000673_model.species_labels"
},
{
"name": "pd_ce_p",
"maps_to": "systemsbiology_sbml_lockwood2006_alzheimer_s_disease_pbpk_model_biomd0000000673_model.pd_ce_p"
},
{
"name": "pd_ce_a",
"maps_to": "systemsbiology_sbml_lockwood2006_alzheimer_s_disease_pbpk_model_biomd0000000673_model.pd_ce_a"
},
{
"name": "model_inactive",
"maps_to": "systemsbiology_sbml_lockwood2006_alzheimer_s_disease_pbpk_model_biomd0000000673_model.model_inactive"
},
{
"name": "model_active_u_shaped",
"maps_to": "systemsbiology_sbml_lockwood2006_alzheimer_s_disease_pbpk_model_biomd0000000673_model.model_active_u_shaped"
},
{
"name": "model_active_sigmoidal",
"maps_to": "systemsbiology_sbml_lockwood2006_alzheimer_s_disease_pbpk_model_biomd0000000673_model.model_active_sigmoidal"
},
{
"name": "model_active_linear",
"maps_to": "systemsbiology_sbml_lockwood2006_alzheimer_s_disease_pbpk_model_biomd0000000673_model.model_active_linear"
}
]
},
"tags": [
"neuroscience",
"pharmacology",
"systemsbiology",
"sbml",
"biomodels_ebi",
"faithful",
"curated"
],
"title": "Lockwood2006 Alzheimer S Disease Pbpk Lab",
"models": [
{
"path": "models/core",
"alias": "systemsbiology_sbml_lockwood2006_alzheimer_s_disease_pbpk_model_biomd0000000673_model"
},
{
"path": "models/visualisation",
"alias": "visualisation"
}
],
"wiring": [
{
"to": [
"visualisation.systemsbiology_sbml_lockwood2006_alzheimer_s_disease_pbpk_model_biomd0000000673_model_state"
],
"from": "systemsbiology_sbml_lockwood2006_alzheimer_s_disease_pbpk_model_biomd0000000673_model.state"
},
{
"to": [
"visualisation.systemsbiology_sbml_lockwood2006_alzheimer_s_disease_pbpk_model_biomd0000000673_model_summary"
],
"from": "systemsbiology_sbml_lockwood2006_alzheimer_s_disease_pbpk_model_biomd0000000673_model.summary"
},
{
"to": [
"visualisation.systemsbiology_sbml_lockwood2006_alzheimer_s_disease_pbpk_model_biomd0000000673_model_species_labels"
],
"from": "systemsbiology_sbml_lockwood2006_alzheimer_s_disease_pbpk_model_biomd0000000673_model.species_labels"
}
],
"package": "lockwood2006-alzheimer-s-disease-pbpk",
"runtime": {
"duration": 1,
"initial_inputs": {},
"communication_step": 0.1
},
"version": "1.0.0",
"description": "Lockwood2006 - AlzheimersDisease PBPKmodel A mathematical model to predict theeffectiveness of CI-1017 (muscarinic agonist) for Alzheimer'sdisease by evaluating changes in ADAS-cog score. It can be used to explore systemsbiology lockwood2006 alzheimer s disease pbpk dynamics and compare simulation behavior across conditions.",
"schema_version": "2.0"
}Runtime
Duration1
Comms Step0.1
Runs
Total0
Completed0
Failed0
Metadata
Packagelockwood2006-alzheimer-s-disease-pbpk
Created2026-05-17
Updated2026-06-13
neurosciencepharmacologysystemsbiologysbmlbiomodels_ebifaithfulcuratedvisualisationother